As previously proposed, IGF‐1R inhibitors could induce apoptosis, inhibit tumor growth, as well as sensitize cells to chemotherapy in esophageal carcinoma cells 29, 30. This evidence concerns the gene IGF1R and carcinoma of esophagus.